Literature DB >> 9343185

Readthrough activation of early adenovirus E1b gene transcription.

L F Maxfield1, D J Spector.   

Abstract

In cells productively infected with adenovirus type 5, transcription is not terminated between the E1a gene and the adjacent downstream E1b gene. Insertion of the mouse beta(maj)-globin transcription termination sequence (GGT) into the E1a coding region dramatically reduces early, but not late, E1b expression (E. Falck-Pedersen, J. Logan, T. Shenk, and J. E. Darnell, Jr., Cell 40:897-905, 1985). In the study described herein, we showed that base substitution mutations in the globin DNA that specifically relieved transcription termination also restored early E1b promoter activity in cis, establishing that maximal early E1b expression requires readthrough transcription originating from the adjacent upstream gene. To identify potential targets of readthrough activation, a series of recombinant viruses with double mutations was constructed. Each double-mutant virus strain had the transcription termination sequences in the first exon of E1a and a deletion within the transcription control region of E1b. Early E1b expression from the double-mutant strains was more defective than that from strains containing either mutation alone, indicating that the deleted regions (positions -362 to -35) are not the target for readthrough activation. Two findings suggested that a cis-dominant property of early viral templates is important for readthrough activation. First, the early E1b defect caused by the GGT insertion was not complemented in trans by factors present in late-infected cells. Second, restoration of E1b transcription at late times occurred concurrently with viral DNA replication. Readthrough activation may help convert virion DNA into a transcriptionally competent template prior to DNA replication and late transcription.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9343185      PMCID: PMC192291     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  RNA synthesis and processing in adenovirus-infected cells.

Authors:  L Philipson; U Pettersson; U Lindberg; C Tibbetts; B Vennström; T Persson
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

2.  Transcription termination within the E1A gene of adenovirus induced by insertion of the mouse beta-major globin terminator element.

Authors:  E Falck-Pedersen; J Logan; T Shenk; J E Darnell
Journal:  Cell       Date:  1985-04       Impact factor: 41.582

3.  Inhibition of RNA cleavage but not polyadenylation by a point mutation in mRNA 3' consensus sequence AAUAAA.

Authors:  C Montell; E F Fisher; M H Caruthers; A J Berk
Journal:  Nature       Date:  1983 Oct 13-19       Impact factor: 49.962

4.  Effect on transformation of mutations in the early region 1b-encoded 21- and 55-kilodalton proteins of adenovirus 5.

Authors:  L E Babiss; P B Fisher; H S Ginsberg
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

5.  Purification of an adenovirus-coded DNA polymerase that is required for initiation of DNA replication.

Authors:  B W Stillman; F Tamanoi; M B Mathews
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

6.  The genetic analysis of recombination using adenovirus overlapping terminal DNA fragments.

Authors:  F C Volkert; C S Young
Journal:  Virology       Date:  1983-02       Impact factor: 3.616

7.  The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer element.

Authors:  P Hearing; T Shenk
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

8.  The structure of adenovirus 2 early nuclear and cytoplasmic RNAs.

Authors:  G R Kitchingman; H Westphal
Journal:  J Mol Biol       Date:  1980-02-15       Impact factor: 5.469

9.  Expression of early adenovirus genes requires a viral encoded acidic polypeptide.

Authors:  R P Ricciardi; R L Jones; C L Cepko; P A Sharp; B E Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

10.  Sequence-independent autoregulation of the adenovirus type 5 E1A transcription unit.

Authors:  P Hearing; T Shenk
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

View more
  8 in total

1.  Replicating adenoviruses that target tumors with constitutive activation of the wnt signaling pathway.

Authors:  M Brunori; M Malerba; H Kashiwazaki; R Iggo
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  E1B-55K Is a Phosphorylation-Dependent Transcriptional and Posttranscriptional Regulator of Viral Gene Expression in Human Adenovirus C5 Infection.

Authors:  Paloma Hidalgo; Yasel Garcés; Eduardo Mundo; Raúl E López; Luca D Bertzbach; Thomas Dobner; Ramón A González
Journal:  J Virol       Date:  2022-01-12       Impact factor: 6.549

3.  Local character of readthrough activation in adenovirus type 5 early region 1 transcription control.

Authors:  Li Shen; David J Spector
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

4.  Studies of the mechanism of transactivation of the adeno-associated virus p19 promoter by Rep protein.

Authors:  Daniel F Lackner; Nicholas Muzyczka
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

5.  Read-through activation of transcription in a cellular genomic context.

Authors:  Li Shen; David J Spector
Journal:  PLoS One       Date:  2010-12-28       Impact factor: 3.240

6.  DNA replication-dependent binding of CTCF plays a critical role in adenovirus genome functions.

Authors:  Tetsuro Komatsu; Takeshi Sekiya; Kyosuke Nagata
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

7.  Adenovirus E1A Activation Domain Regulates H3 Acetylation Affecting Varied Steps in Transcription at Different Viral Promoters.

Authors:  Emily Hsu; Mario A Pennella; Nathan R Zemke; Carol Eng; Arnold J Berk
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

8.  The Human Adenovirus Type 2 Transcriptome: An Amazing Complexity of Alternatively Spliced mRNAs.

Authors:  Amanda Westergren Jakobsson; Bo Segerman; Ola Wallerman; Sara Bergström Lind; Hongxing Zhao; Carl-Johan Rubin; Ulf Pettersson; Göran Akusjärvi
Journal:  J Virol       Date:  2020-11-25       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.